Peptide library › Growth hormone axis
Somapacitan
Also known as Sogroya
Once-weekly growth hormone treatment for children and adults with growth hormone deficiency.
What people use it for
- Growth hormone deficiency in adults
- Growth hormone deficiency in children
- Some causes of short stature in children
What Somapacitan does in the body
Growth hormone with a small change that lets it bind to albumin in the blood, so it lasts long enough for one injection a week instead of daily.
Strength of evidence
Strong: Phase 3 trials showed similar results to daily growth hormone.
Look up the evidence
- Reviews on PubMed: Summaries of the published research
- Clinical trials on PubMed: Published studies in people
- ClinicalTrials.gov: Registered trials, past and ongoing
- Prescribing information (DailyMed, US): Official US label
- Patient leaflets (emc, UK): Official UK product information
Live searches of official databases. New to the terms? See the glossary.
Reported side effects & risks
- Headache
- Joint pain
- Swelling
- Injection-site reactions
- Higher blood sugar
Who should avoid it or take extra care
- Active cancer
- Severe acute illness
- Diabetic eye disease (proliferative retinopathy)
Not a complete list. Check with a doctor or pharmacist about your own health and medicines.
Regulatory status
FDA-approved in 2020 for adults, with children's growth hormone deficiency added in 2023 and further children's short-stature uses later. Prescription only.
How it's taken
Route: Injection under the skin, once weekly
How long it lasts (half-life): About 2 to 3 days
Storage
Refrigerated before first use; follow the pen instructions afterwards.
Keep track of Somapacitan privately
Fiala is a free app for logging doses, tracking vials and setting reminders. No account, and everything you log stays on your phone.
Open Somapacitan in Fiala How to installMore in Growth hormone axis
- TesamorelinGHRH analog approved to reduce excess abdominal fat in people with HIV-associated lipodystrophy.
- SermorelinShort GHRH fragment that stimulates natural growth hormone release.
- CJC-1295Long-acting GHRH analog, often paired with ipamorelin in popular protocols.
- IpamorelinSelective growth hormone secretagogue (ghrelin-receptor agonist).
- HexarelinPotent synthetic growth hormone secretagogue related to GHRP-6.
- GHRP-2Synthetic growth hormone–releasing peptide used in Japan as a diagnostic test.
- GHRP-6First-generation growth hormone–releasing hexapeptide known for strong hunger effects.
- IGF-1 LR3Modified, longer-acting form of insulin-like growth factor 1.
- IGF-1 DESShortened, fast-acting form of insulin-like growth factor 1 sold as a research chemical.
- MK-677Oral growth hormone secretagogue. It is not a peptide, but is commonly tracked alongside them.
- Fragment 176-191Small piece of the growth hormone molecule sold online for fat loss; evidence is from animals only.
- SomatropinLab-made human growth hormone, identical to the body's own, used for growth hormone deficiency and some growth disorders.
- MecaserminLab-made IGF-1 for children who can't grow normally because their bodies don't make enough IGF-1.
- PegvisomantBlocks growth hormone's effects; used for acromegaly, a condition caused by too much growth hormone.